Phase II Rx

by HoltraCeuticals · capsule · 120 vegetable capsules

  • On the market (NIH)
  • UPC 8 71149 00628 0
  • DSLD label 19834
  • Serving 1 capsule
  • 120 servings

Phase II Rx by HoltraCeuticals lists 2 ingredients, 2 with an amount per serving of 1 capsule, such as 230 mg of broccoli seed extract. Its current label entered the NIH Dietary Supplement Label Database on March 25, 2013.

What is in Phase II Rx?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Phase II Rx: Supplement Facts rows against the market (DSLD label 19834, January 2026 release)
IngredientAmount% DVAmong products listing it
Broccoli seed extract230 mgBroccoli in Phase II Rx against 530 products230 mg per serving; the middle half of products list 40 mg to 250 mg, the median 100 mg.230 mg

Higher than 71% of 530 products listing broccoli (median 100 mg).

Providing 30 mg Sulforaphane Glucosinolate30 mgGlucoraphanin in Phase II Rx against 79 products30 mg per serving; the middle half of products list 15 mg to 33.85 mg, the median 30 mg.30 mg

27% of 79 products listing glucoraphanin give more (median 30 mg).

Source: NIH ODS Dietary Supplement Label Database, label 19834 (entered March 25, 2013), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Directions: Take one capsule daily or as directed by your healthcare practitioner.
Warnings
CAUTION: Keep out of reach of children.
Allergens and what it does not contain
DOES NOT CONTAIN: Wheat, gluten, corn protein, yeast, soy, diary products, artificial colors, sweeteners or preservatives.
Storage
STORAGE: Keep tightly closed in a cool, dry place.

Source: label statements in DSLD label 19834.

What else is on the label?

Other ingredients: HPMC, Microcrystalline Cellulose, Stearic Acid, Silicon Dioxide, Magnesium Stearate.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): Vegetable CAPSULES; sgs(TM); {recycle}.

How many labels does Phase II Rx have?

One label is on file, entered on March 25, 2013.

  1. Label 19834 (current) Entered March 25, 2013 · on the market · 120 vegetable capsules · UPC 8 71149 00628 0

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Kent Holtorf, M.D., & the Holtorf Medical Group., Inc (distributor), Torrance, CA. All HoltraCeuticals products.

Where next?